Log In
Sign Up
Imatinib Mesylate
Chronic and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (CML) in adult patients resistant to or intolerant to prior therapy
400-800mg daily. [Doses of 400mg or 600 mg should be administered OD, whereas a dose of 800 mg should be administered as 400 mg BD].
Mode of action
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us